Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3Lymphoid 1

Conditions

Peritoneal Neoplasms 1Ovarian Neoplasms 1Krukenberg Tumor 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 92Cisplatin 67Specimen Handling 63Magnetic Resonance Spectroscopy 52olaparib 51Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Doxorubicin 26Topotecan 25Letrozole 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21durvalumab 20Surveys and Questionnaires 20Disulfides 20dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Laparotomy × Gynecologic × 1 year × Clear all
NCT06790004 2026-05-07

LPSvsLPT

Azienda USL Reggio Emilia - IRCCS

Active not recruiting
700 enrolled
Gynecologic

Endometrial Neoplasms

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
150 enrolled
Gynecologic

Krukenberg Tumor, Peritoneal Neoplasms

NCT04575935 2026-03-05

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

M.D. Anderson Cancer Center

Phase 3 Recruiting
580 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡